IMMORNA

Immorna

Biotechnology, 1 Park PLZ, Morrisville, North Carolina, 37203, United States, 51-200 Employees

immorna.com

  • LinkedIn

phone no Phone Number: 98********

Who is IMMORNA

Immorna is a rapidly expanding biotechnology company, focusing on the development of mRNA-based therapeutics and vaccines. Immorna is utilizing multiple mRNA platforms, including conventi...

Read More

map
  • 1 Park PLZ, Morrisville, North Carolina, 37203, United States Headquarters: 1 Park PLZ, Morrisville, North Carolina, 37203, United States
  • 2019 Date Founded: 2019
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 6719

checked-icon Does something look wrong? Fix it. | View contact records from IMMORNA

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding IMMORNA

Answer: IMMORNA's headquarters are located at 1 Park PLZ, Morrisville, North Carolina, 37203, United States

Answer: IMMORNA's phone number is 98********

Answer: IMMORNA's official website is https://immorna.com

Answer: IMMORNA's revenue is $1 Billion and Over

Answer: IMMORNA's SIC: 6719

Answer: IMMORNA has 51-200 employees

Answer: IMMORNA is in Biotechnology

Answer: IMMORNA contact info: Phone number: 98******** Website: https://immorna.com

Answer: Immorna is a rapidly expanding biotechnology company, focusing on the development of mRNA-based therapeutics and vaccines. Immorna is utilizing multiple mRNA platforms, including conventional, self-replicating and circular mRNA. Since its founding in 2019, Immorna has built a robust CMC platform for mRNA synthesis, purification, and analytical testing that is well suited for clinical and commercial development. In addition, with its state-of-the-art screening tools, Immorna has developed an arsenal of mRNA delivery vehicles, including polymers and lipid nanoparticles featuring multiple proprietary ionizable cationic lipids suitable for intramuscular, intravenous and tissue-targeting delivery. Immorna has a growing intellectual property portfolio and a diverse mRNA development pipeline spanning cancer immunotherapy, infectious diseases, rare genetic diseases, and medical cosmetology, and quickly advancing its oncology and infectious disease drug candidates into their clinical stages.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access